121 related articles for article (PubMed ID: 1718495)
21. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells.
Hiroi T; Maruyama K; Hattori K; Ohnuki T; Nagatomo T; Watanabe K; Yamamoto T; Hara Y
Jpn J Pharmacol; 1997 May; 74(1):37-43. PubMed ID: 9195295
[TBL] [Abstract][Full Text] [Related]
22. Characterization of thromboxane A2/prostaglandin H2 receptors and histamine H1 receptors in cultured guinea-pig tracheal smooth-muscle cells.
Miki I; Nonaka H; Ishii A
Biochim Biophys Acta; 1992 Oct; 1137(1):107-15. PubMed ID: 1356444
[TBL] [Abstract][Full Text] [Related]
23. Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
Monshizadegan H; Hedberg A; Webb ML
Life Sci; 1992; 51(6):431-7. PubMed ID: 1386132
[TBL] [Abstract][Full Text] [Related]
24. Elevation of platelet cyclic AMP level by thromboxane A2/prostaglandin H2 receptor agonists.
Ishikawa Y; Ogawa A
Thromb Res; 1991 Dec; 64(6):667-76. PubMed ID: 1665927
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets.
Murray R; Shipp E; FitzGerald GA
J Biol Chem; 1990 Dec; 265(35):21670-5. PubMed ID: 1701435
[TBL] [Abstract][Full Text] [Related]
26. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
27. The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
Stürzebecher S; Witt W
Prostaglandins; 1988 Dec; 36(6):751-60. PubMed ID: 2469101
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
Hung SC; Ghali NI; Venton DL; Le Breton GC
Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
[TBL] [Abstract][Full Text] [Related]
29. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
Eggerman TL; Andersen NH; Robertson RP
J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
[TBL] [Abstract][Full Text] [Related]
30. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
Miki I; Kase H; Ishii A
Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
[TBL] [Abstract][Full Text] [Related]
31. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
[TBL] [Abstract][Full Text] [Related]
32. Concurrent down-regulation of IP prostanoid receptors and the alpha-subunit of the stimulatory guanine-nucleotide-binding protein (Gs) during prolonged exposure of neuroblastoma x glioma cells to prostanoid agonists. Quantification and functional implications.
Adie EJ; Mullaney I; McKenzie FR; Milligan G
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):529-36. PubMed ID: 1379045
[TBL] [Abstract][Full Text] [Related]
33. A prostaglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells.
Sonnenburg WK; Zhu JH; Smith WL
J Biol Chem; 1990 May; 265(15):8479-83. PubMed ID: 2111319
[TBL] [Abstract][Full Text] [Related]
34. Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties.
Brass LF; Woolkalis MJ
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):73-80. PubMed ID: 1310010
[TBL] [Abstract][Full Text] [Related]
35. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
36. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
37. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
38. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist.
Hanasaki K; Arita H
Biochim Biophys Acta; 1989 Sep; 1013(1):28-35. PubMed ID: 2528990
[TBL] [Abstract][Full Text] [Related]
39. Cyclic AMP does not inhibit collagen-induced platelet signal transduction.
Smith JB; Dangelmaier C; Selak MA; Ashby B; Daniel J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):889-92. PubMed ID: 1375452
[TBL] [Abstract][Full Text] [Related]
40. [3H]iloprost and prostaglandin E2 compete for the same receptor site on cardiac sarcolemmal membranes.
Lerner RW; Lopaschuk GD; Catena RC; Olley PM
Biochim Biophys Acta; 1992 Apr; 1105(2):189-92. PubMed ID: 1375098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
